You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Amgen Inc. (AMGN $355.60)
- $355.60 P/E (TTM): 24.58X Cap: $191.91B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $767.85)
- $767.85 P/E (TTM): 18.7X Cap: $81.17B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $446.78)
- $446.78 P/E (TTM): 29.03X Cap: $113.68B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $172.16)
- $172.16 P/E (TTM): 20.63X Cap: $8.30B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,335.00)
- $1,335.00 P/E (TTM): 31.4X Cap: $27.03B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $8.10)
- $8.10 Cap: $789M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $11.21)
- $11.21 Cap: $39M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use